A01K 2217/20
Animal model comprising regulated expression system
A01K2217/20 (Animal model comprising regulated expression system) appears on 516 US grants and 997 published applications in this corpus.
Search patents in A01K- Granted patents
- 516
- Published applications
- 997
- Assignees
- 487
- Inventors
- 1,895
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 5 | 0 |
| 1997 | 4 | 0 |
| 1998 | 9 | 0 |
| 1999 | 13 | 0 |
| 2000 | 13 | 0 |
| 2001 | 8 | 1 |
| 2002 | 7 | 50 |
| 2003 | 8 | 30 |
| 2004 | 11 | 33 |
| 2005 | 6 | 19 |
| 2006 | 6 | 25 |
| 2007 | 8 | 9 |
| 2008 | 8 | 15 |
| 2009 | 6 | 19 |
| 2010 | 6 | 56 |
| 2011 | 12 | 49 |
| 2012 | 20 | 35 |
| 2013 | 21 | 42 |
| 2014 | 13 | 28 |
| 2015 | 31 | 52 |
| 2016 | 25 | 44 |
| 2017 | 37 | 41 |
| 2018 | 31 | 59 |
| 2019 | 21 | 62 |
| 2020 | 24 | 50 |
| 2021 | 30 | 44 |
| 2022 | 33 | 61 |
| 2023 | 35 | 42 |
| 2024 | 21 | 51 |
| 2025 | 22 | 51 |
| 2026 | 16 | 29 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Neurodegenerative and amyotrophic model animal25 Aug 2026US 12,714,076 B2Tokyo Metropolitan Institute of Medical Science
- Multi-transgenic pig for Xenotransplantation25 Aug 2026US 12,714,077 B2Revivicor, Inc.
- Artificial expression constructs for selectively modulating gene expression in selected neuronal cell populations11 Aug 2026US 12,702,722 B2Allen Insitute
- Compositions comprising miR-690 and methods therefor16 Jun 2026US 12,653,783 B2The Regents of the University of California
- Multitransgenic pigs comprising ten genetic modifications for xenotransplantation9 Jun 2026US 12,648,548 B2Revivicor, Inc.
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Non-human animal, kit, and method for producing replacement organ24 Sep 2026US 2026/0283124 A1The Jikei University
- Methods of eliciting immuno-tolerance using soluble immune checkpoint proteins27 Aug 2026US 2026/0250716 A1Duke University
- Genetically modified pig production method, established somatic cell, and raw material for producing genetically modified pig20 Aug 2026US 2026/0240127 A1Pormedtec Co., Ltd.
- Functional nucleic acid molecule and method20 Aug 2026US 2026/0241035 A1The University Court of the University of Edinburgh
Most cited
By later US patents
- Generation of Xenogenetic antibodies561US 6,162,963 AAbgenix, Inc. · 2000
- Transgenic non-human mammals531US 4,736,866 APresident and Fellows of Harvard College · 1988
- Generation of xenogeneic antibodies295US 6,673,986 B1Abgenix, Inc. · 2004
- DNA sequences to target proteins to the mammary gland for efficient secretion214US 5,304,489 AGenPharm International, Inc. · 1994
- Methods for regulating gene expression170US 5,814,618 ABASF SE · 1998